6533b82efe1ef96bd1292907

RESEARCH PRODUCT

A Combination of Celecoxib and Glucosamine Sulfate Has Anti-Inflammatory and Chondroprotective Effects: Results from an In Vitro Study on Human Osteoarthritic Chondrocytes

Nicola VeroneseStefano GiannottiSara CheleschiAntonella FioravantiJean-yves ReginsterSara Tenti

subject

Interleukin-1betachondrocytesAnti-Inflammatory AgentsApoptosisPharmacologymedicine.disease_causeNF-κBchemistry.chemical_compoundchondroprotectionoxidative stressSulfonesBiology (General)SpectroscopyCells CulturedGlucosamineglucosamine sulfatebiologycelecoxibChemistrySuperoxideNF-kappa BGeneral MedicineComputer Science ApplicationsChemistrychondrocyteosteoarthritiDrug Therapy Combinationmedicine.symptomInflammation Mediatorsmedicine.drugSignal TransductionNF-BQH301-705.5Cell SurvivalGlucosamine SulfateCatalysisArticleInorganic ChemistrySuperoxide dismutaseNitrilesOsteoarthritismedicineHumansPhysical and Theoretical ChemistryQD1-999Molecular Biologyoxidative streOrganic ChemistryMechanism of actionApoptosisinflammationbiology.proteinCelecoxibCyclooxygenaseOxidative stress

description

This study investigated the possible anti-inflammatory and chondroprotective effects of a combination of celecoxib and prescription-grade glucosamine sulfate (GS) in human osteoarthritic (OA) chondrocytes and their possible mechanism of action. Chondrocytes were treated with celecoxib (1.85 µM) and GS (9 µM), alone or in combination with IL-1β (10 ng/mL) and a specific nuclear factor (NF)-κB inhibitor (BAY-11-7082, 1 µM). Gene expression and release of some pro-inflammatory mediators, metalloproteinases (MMPs), and type II collagen (Col2a1) were evaluated by qRT-PCR and ELISA

yearjournalcountryeditionlanguage
2021-08-20International Journal of Molecular Sciences
10.3390/ijms22168980http://europepmc.org/articles/PMC8396455